SEP 9, 2026 · PHASE 2 TRIAL
A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam)
ClinicalTrials.gov
This is a Phase 2 trial registration with no posted results; it describes planned enrollment and outcomes but reports no efficacy or safety data.
Reported
Planned enrollment406
PhasePhase 2
Follow-up duration72 weeks